27bd2ebb5916efe1…

{
  "id": "NCT00034762",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to evaluate the efficacy and safety of risperidone compared with placebo in the treatment of psychotic symptoms in patients with Alzheimer's disease",
    "completionDate": "2003-01",
    "conditions": [
      "Dementia",
      "Alzheimer Disease",
      "Mental Disorders"
    ],
    "enrollmentCount": 473,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00034762",
    "phase": "PHASE3",
    "sponsorId": "johnson-johnson-pharmaceutical-research-development-l-l-c",
    "startDate": "2000-12",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease.",
    "url": "https://clinicaltrials.gov/study/NCT00034762"
  }
}